These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Response to "Results, rhetoric, and randomized trials: the case of donepezil". Lisi D J Am Geriatr Soc; 2009 Jul; 57(7):1317-8; author reply 1318. PubMed ID: 19570171 [No Abstract] [Full Text] [Related]
4. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory. Baxter T; Black D; Prempeh H BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011 [No Abstract] [Full Text] [Related]
5. Ignoring the controversies: newspaper reports on Alzheimer's disease treatments. Adelman EE; Karlawish JH J Am Geriatr Soc; 2003 Dec; 51(12):1821-2. PubMed ID: 14687373 [No Abstract] [Full Text] [Related]
8. [Donepezil in Alzheimer's disease and vascular dementia]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):71-5. PubMed ID: 24073452 [No Abstract] [Full Text] [Related]
9. Efficacy of donepezil in Alzheimer's disease: fact or artifact? van Gool WA Neurology; 1999 Jan; 52(1):218-9. PubMed ID: 9921890 [No Abstract] [Full Text] [Related]
10. No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment. Auriacombe S; Pere JJ; Curr Med Res Opin; 2003; 19(8):715-7. PubMed ID: 14687442 [No Abstract] [Full Text] [Related]
11. Use of donepezil for the treatment of mild-moderate Alzheimer's disease: an audit of the assessment and treatment of patients in routine clinical practice. Cameron I; Curran S; Newton P; Petty D; Wattis J Int J Geriatr Psychiatry; 2000 Oct; 15(10):887-91. PubMed ID: 11044869 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy, efficiency and evidence -- studies on donepezil]. Wallesch CW; Ebert AD Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778 [No Abstract] [Full Text] [Related]
13. Effectiveness of donepezil in treating Alzheimer's disease. Garcia A Can Fam Physician; 1999 Aug; 45():1858-9. PubMed ID: 10463081 [No Abstract] [Full Text] [Related]
14. Improving functioning in patients with Alzheimer's. J Psychosoc Nurs Ment Health Serv; 1998 May; 36(5):11-2. PubMed ID: 9604834 [No Abstract] [Full Text] [Related]
15. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60]. Vollmar HC; Butzlaff M Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187 [No Abstract] [Full Text] [Related]
17. Investigation of responders and non-responders to long-term donepezil treatment. Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N Psychogeriatrics; 2010 Jun; 10(2):53-61. PubMed ID: 20738808 [TBL] [Abstract][Full Text] [Related]
18. Donepezil and athetosis in an elderly patient with Alzheimer's disease. Tanaka M; Yokode M; Kita T; Matsubayashi K J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588 [No Abstract] [Full Text] [Related]
19. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project. Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851 [No Abstract] [Full Text] [Related]
20. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]